AgeneBio
AgeneBio's mission is to discover and develop innovative therapeutics for patients at risk for neurological and psychiatric conditions. Our lead late-stage clinical program is focused on prevention of Alzheimer’s dementia.
Private Company
Total funding raised: $127.5M
About
AgeneBio's mission is to discover and develop innovative therapeutics for patients at risk for neurological and psychiatric conditions. Our lead late-stage clinical program is focused on prevention of Alzheimer’s dementia.
Small Molecules
Funding History
3Total raised:$127.5M
Series C$45M
Series B$35M
Series A$47.5M